Trump’s Psychedelic Order: Breakthrough...or Bad Trip?
About this episode
The episode discusses President Trump's executive order to enhance research on psychedelic drugs for mental health treatments, featuring insights from advocates and medical experts.
President Donald Trump signed an executive order on Saturday aimed at beefing up research of psychedelic drugs like ibogaine that could be used in mental health treatments. Some veterans and people who have struggled with addiction who have used ibogaine say this could be a breakthrough that could lead to wider access, but some medical experts are warning approvals shouldn’t be rushed. We hear why a leading advocate group says while it’s a good start – much more has to be done. For more: Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’ --- Guests: Samantha Juan & Melissa Lavasani, Psychedelic Medicine Coalition Founder/CEO Host: David Rind Producer: Paola Ortiz Showrunner: Felicia Patinkin Editorial Support: Katherine Dillinger Photo: Jim Watson/AFP/Getty Images Learn more about your ad choices. Visit podcastchoices.com/adchoices
People in this episode
Host: David Rind
Guests: Samantha Juan, Melissa Lavasani
Topics covered
- psychedelic drugs
- mental health treatments
- executive order
- ibogaine
- veterans
- addiction
- medical research
Keywords
- Trump
- psychedelic drugs
- ibogaine
- mental health
- addiction
- executive order
- research
- veterans
- treatment
Mentioned in this episode
Organizations: Psychedelic Medicine Coalition, CNN Podcasts
More episodes of CNN One Thing
- Remembering Ted Turner
- Missing Scientists, Assassination Attempts, & Conspiracy Theories Under Trump 2.0
- The ‘Special Relationship’ Is Strained. King Charles to the Rescue?
- Musk vs. Altman & The Battle for The Soul of AI
- A Former NASA Scientist Turns Anger Into Action
- Vance Gets His Time in the Spotlight. Did He Drop the Ball?
Explore listener stats, chart rankings, contacts and more on the CNN One Thing podcast page.